Foley creates four-partner team in Salt Lake City office Despite the launch of Foley's office in Silicon Slopes, national law firms are still interested in the location Six new litigators have...
US Senate approves US innovation and Competition Act 2021, competing China's tech rise In view of competing with Chinese technology, the United States advanced a package of legislation for boosting...
International IP Index 2021: US tops the list, China and India shows maximum increase Recently, the US Chamber of Commerce Global Innovation Policy Center (GIPC) released their Ninth Annual...
Cell Source received two Patents for their Veto Cell Technology Cell Source centers itself with the cellular therapy and immunotherapy platform technologies for treating blood cancer and more...
Access by Improvement to Patented Technologies Possibly, such "Opening Clauses" would not only be useful in heavily patented areas like telecommunication to get enforced access to SEP-surrounded...
European Patent Office comes up with Guidelines for Examination 2021: Part I The Guidelines for Examination 2021, published by European Patent Office (EPO) came into force on March 1. Through these...
European Patent Office comes up with Guidelines for Examination 2021: Part II The Guidelines for Examination 2021, published by European Patent Office (EPO) came into force on March 1. In part I, we...
Nokia and Samsung sign the Patent Licensing Pact The Finnish multinational telecommunication and consumer electronic giant, Nokia has initiated a deal with Samsung for licensing its patent covering...
Thailand signs MOU with e-commerce for combating online IP infringement Teaming up with e-commerce and IP owners, the Commerce Ministry of Thailand has signed an MOU for combating online...
Revisiting well-trodden areas of Patent Law The latest case of Vectura vs. GlaxoSmithKline offers various insights on well-versed areas of patent law. This case touched upon aspects such as claim...
Invalidation of Patents through Indefiniteness The latest case of Horizon Pharma vs. Dr. Reddy touches upon an important aspect of drafting the specification and indefiniteness in the US Patent...
